Akari Therapeutics' Other Investors

Akari Therapeutics raised a round of funding on , . Investors include New Enterprise Associates.

Akari, formerly Celsus Therapeutics, is a clinical-stage biopharmaceutical company focused on the development and commercialization of therapeutics to treat orphan autoimmune and inflammatory diseases…

Articles about Akari Therapeutics' Other Investors: